CDC’s real-world findings provide reassurance about Pfizer-BioNTech, Moderna vaccine effectiveness in the highest-risk age group
NOTE: This article is provide to all to read free of charge by The Washington Post.
The Pfizer-BioNTech and Moderna vaccines being deployed to fight the coronavirus pandemic are highly effective in preventing hospitalizations among older adults, the group most at risk for severe disease and death, according to afederal study released Wednesday.
While not surprising, the results are reassuring because they provide the first real-world evidence in the United States that both vaccines prevent severe covid-19 illness, as they did in clinical trials, the Centers for Disease Control and Prevention said.
In the study, fully vaccinated adults 65 and older were 94 percent less likely to be hospitalized with covid-19 than than unvaccinated people of the same age, according to the CDC. People who were partially vaccinated were 64 percent less likely to be hospitalized with the disease than the unvaccinated.